Hepatitis

PCORI approves $83 million for HCV, rare disease research

Publish date: September 29, 2015

Publish date: September 23, 2015

The combination of sofosbuvir and velpatasvir had treatment success rates ranging from 98% in three of four phase III trials to 83% for patients...

Publish date: September 8, 2015

Patients with hepatitis C and psychiatric disorders or substance abuse problems benefit significantly from an integrated care model of treatment...

Publish date: September 3, 2015

Patients with chronic hepatitis C who develop cirrhosis with severe portal hypertension are at greater risk of progressing to liver decompensation...

Publish date: August 29, 2015

More than 28% of patients with chronic hepatitis C virus infection met at least one criterion for cirrhosis, while only 7% had biopsy confirmation...